These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
686 related items for PubMed ID: 15756026
1. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ. Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026 [Abstract] [Full Text] [Related]
2. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS, Davis TW, Ornberg RL, Masferrer JL. Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270 [Abstract] [Full Text] [Related]
3. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines. Buecher B, Bouancheau D, Broquet A, Bezieau S, Denis MG, Bonnet C, Heymann MF, Jarry A, Galmiche JP, Blottière HM. Anticancer Res; 2005 Nov 15; 25(1A):225-33. PubMed ID: 15816542 [Abstract] [Full Text] [Related]
4. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N. Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455 [Abstract] [Full Text] [Related]
5. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Cui W, Yu CH, Hu KQ. Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255 [Abstract] [Full Text] [Related]
6. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells. Niederberger E, Manderscheid C, Grösch S, Schmidt H, Ehnert C, Geisslinger G. Biochem Pharmacol; 2004 Jul 15; 68(2):341-50. PubMed ID: 15194006 [Abstract] [Full Text] [Related]
7. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G. FASEB J; 2001 Dec 15; 15(14):2742-4. PubMed ID: 11606477 [Abstract] [Full Text] [Related]
8. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines. Waskewich C, Blumenthal RD, Li H, Stein R, Goldenberg DM, Burton J. Cancer Res; 2002 Apr 01; 62(7):2029-33. PubMed ID: 11929821 [Abstract] [Full Text] [Related]
9. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase. Kim SH, Kim SH, Song YC, Song YS. Ann N Y Acad Sci; 2009 Aug 01; 1171():635-41. PubMed ID: 19723114 [Abstract] [Full Text] [Related]
10. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth. Liu W, Chen Y, Wang W, Keng P, Finkelstein J, Hu D, Liang L, Guo M, Fenton B, Okunieff P, Ding I. Am J Clin Oncol; 2003 Aug 01; 26(4):S103-9. PubMed ID: 12902866 [Abstract] [Full Text] [Related]
11. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro]. Zhu FS, Chen XM, Wang YJ, Zhang X, Feng JX. Zhonghua Zhong Liu Za Zhi; 2007 Mar 01; 29(3):186-8. PubMed ID: 17649633 [Abstract] [Full Text] [Related]
12. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K. Int J Oncol; 2003 Sep 01; 23(3):665-72. PubMed ID: 12888902 [Abstract] [Full Text] [Related]
13. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN. Cancer Res; 2000 Nov 01; 60(21):6045-51. PubMed ID: 11085526 [Abstract] [Full Text] [Related]
14. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro. Ohneseit PA, Krebiehl G, Dittmann K, Kehlbach R, Rodemann HP. Radiother Oncol; 2007 Feb 01; 82(2):229-38. PubMed ID: 17207548 [Abstract] [Full Text] [Related]
15. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grösch S. Biochem Pharmacol; 2004 Apr 15; 67(8):1469-78. PubMed ID: 15041464 [Abstract] [Full Text] [Related]
16. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Kusunoki N, Yamazaki R, Kawai S. Arthritis Rheum; 2002 Dec 15; 46(12):3159-67. PubMed ID: 12483719 [Abstract] [Full Text] [Related]
17. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors. Narayanan NK, Narayanan BA, Reddy BS. Int J Oncol; 2005 Mar 15; 26(3):785-92. PubMed ID: 15703837 [Abstract] [Full Text] [Related]
18. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL. Cancer Res; 2002 Feb 01; 62(3):625-31. PubMed ID: 11830509 [Abstract] [Full Text] [Related]
19. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS, Liu DS, Dai CW, Li RJ. Am J Hematol; 2006 Apr 01; 81(4):242-55. PubMed ID: 16550520 [Abstract] [Full Text] [Related]
20. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice]. Zuo CH, Li ZR, Zhou X, Ouyang YZ, Zhou ZY, Zeng L. Ai Zheng; 2006 Apr 01; 25(4):414-20. PubMed ID: 16613672 [Abstract] [Full Text] [Related] Page: [Next] [New Search]